- Home
- AEF vs ANGO Comparison
AEF vs ANGO Comparison
Compare AEF & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AEF | ANGO |
|---|---|---|
| Founded | 1989 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.7M | 400.8M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | AEF | ANGO |
|---|---|---|
| Price | $6.72 | $13.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 92.5K | ★ 474.2K |
| Earning Date | 01-01-0001 | 01-07-2026 |
| Dividend Yield | ★ 7.13% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.57 | N/A |
| Revenue | N/A | ★ $300,718,000.00 |
| Revenue This Year | N/A | $8.18 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | $8.86 | ★ N/A |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $4.40 | $8.27 |
| 52 Week High | $5.53 | $13.99 |
Technical Indicators
Market Signals| Indicator | AEF | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 45.68 | 55.89 |
| Support Level | $6.86 | $13.02 |
| Resistance Level | $7.05 | $13.53 |
| Average True Range (ATR) | 0.11 | 0.42 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 13.64 | 51.43 |
Price Performance
Historical ComparisonAbout AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, private equity, communication services, healthcare, real estate, and industrials.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.